The Valley Desk

NCT00150800 · Interventional trial

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

Overall registry status Completed

Phase 3

Conditions Epilepsy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov